An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for ...
The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023. The ...
A recent study published in Cell Reports Medicine has identified distinct microbial signatures within the oral cavity and gut ...
TOBY, Inc., a biotechnology company developing non-invasive cancer screening technologies, today announced that the U.S. Food ...
Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
Caris POA members advance precision medicine through collaborative research aimed at improving clinical outcomes for cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results